These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27889132)

  • 1. [Level at which control objectives are reached in patients in different population groups with type 2 diabetes].
    Herrero A; Pinillos J; Sabio P; Martín JL; Garzón G; Gil Á
    Semergen; 2017; 43(8):550-556. PubMed ID: 27889132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic disorders associated with uncontrolled hypertension.
    Bøg-Hansen E; Lindblad U; Gullberg B; Melander A; Råstam L
    Diabetes Obes Metab; 2003 Nov; 5(6):379-87. PubMed ID: 14617223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.
    Esteghamati A; Abbasi M; Nakhjavani M; Yousefizadeh A; Basa AP; Afshar H
    Cardiovasc Diabetol; 2006 Jul; 5():15. PubMed ID: 16842631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in the control of cardiovascular risk factors in patients with type 2 diabetes -a cross-sectional study.
    Sekerija M; Poljicanin T; Erjavec K; Liberati-Cizmek AM; Prašek M; Metelko Z
    Intern Med; 2012; 51(2):161-6. PubMed ID: 22246483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive symptoms, serious psychological distress, diabetes distress and cardiovascular risk factor control in patients with type 2 diabetes.
    Winchester RJ; Williams JS; Wolfman TE; Egede LE
    J Diabetes Complications; 2016 Mar; 30(2):312-7. PubMed ID: 26657725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.
    Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L
    Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemia and hypertension in patients with type 2 diabetes and retinopathy.
    Popescu T; Moţa M
    Rom J Intern Med; 2009; 47(3):235-41. PubMed ID: 20446438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trends in the level of control of patients with type 2 diabetes from 2010 to 2015].
    Herrero Gil AM; Pinillos Robles J; Sabio Repiso P; Martín Maldonado JL; Garzón González G; Gil de Miguel Á
    Aten Primaria; 2018 Oct; 50(8):459-466. PubMed ID: 28838742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood pressure control in hypertensive Spanish population attended in primary care setting. The PRESCAP 2010 study].
    Llisterri Caro JL; Rodríguez Roca GC; Alonso Moreno FJ; Prieto Díaz MA; Banegas Banegas JR; Gonzalez-Segura Alsina D; Lou Arnal S; Divisón Garrote JA; Beato Fernández P; Barrios Alonso V;
    Med Clin (Barc); 2012 Dec; 139(15):653-61. PubMed ID: 22436384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of cardiovascular risk factor targets according to sex and previous history of cardiovascular disease in type 2 diabetes: A population-based study.
    Galbete A; Cambra K; Forga L; Baquedano FJ; Aizpuru F; Lecea O; Librero J; Ibáñez B
    J Diabetes Complications; 2019 Dec; 33(12):107445. PubMed ID: 31668588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint and distinct risk factors associated with micro- and macrovascular complications in a cohort of type 2 diabetic patients cared through disease management.
    Ciardullo AV; Daghio MM; Bevini M; Feltri G; Novi D; Fattori G; Borsari S; Donato CD
    Acta Diabetol; 2010 Dec; 47(4):301-8. PubMed ID: 20383650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidaemia and hypertension among adults with diabetes in rural Uganda.
    Kamara NT; Asiimwe S
    Trop Doct; 2010 Jan; 40(1):41-2. PubMed ID: 20075425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
    Larrañaga I; Arteagoitia JM; Rodriguez JL; Gonzalez F; Esnaola S; Piniés JA;
    Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases.
    Ruiz-García A; Arranz-Martínez E; García-Álvarez JC; Morales-Cobos LE; García-Fernández ME; de la Peña-Antón N; Martín Calle MC; Díez Pérez MC; Montero Costa A; Palacios Martínez D; García Villasur MP; García Granado MAD; Lorenzo Borda MS; Cique Herráinz JA; Marañón Henrich N; Zarzuelo Martín N; Baltuille Aller MDC; Casaseca Calvo TF; Arribas Álvaro P; Macho Del Barrio AI; Moreno Fernández JC; Ribot Catalá C; Capitán Caldas M; Ciria de Pablo C; Sanz Velasco C; Simonaggio Stancampiano P; Vargas-Machuca Cabañero C; Sarriá Sánchez MT; Gómez Díaz E; Sanz Pozo B; Rodríguez de Mingo E; Cabello Igual MP; Rico Pérez MR; Migueláñez Valero A; Alcaraz Bethencourt A; Zafra Urango C; Chao Escuer P; Redondo de Pedro S; Escamilla Guijarro N; López Uriarte B; Rivera Teijido M;
    Clin Investig Arterioscler; 2018; 30(5):197-208. PubMed ID: 29980384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure.
    Takao T; Kimura K; Suka M; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    J Diabetes Complications; 2015 Jul; 29(5):699-706. PubMed ID: 25861721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes care and complications in a remote primary health care setting.
    Maple-Brown LJ; Brimblecombe J; Chisholm D; O'Dea K
    Diabetes Res Clin Pract; 2004 May; 64(2):77-83. PubMed ID: 15063599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.